Long-Term Follow-Up of Children With Congenital Hyperinsulinism on Octreotide Therapy

Creative Commons License

Demirbilek H., Shah P., Arya V. B., Hinchey L., Flanagan S. E., Ellard S., ...Daha Fazla

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.99, sa.10, ss.3660-3667, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 99 Sayı: 10
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1210/jc.2014-1866
  • Dergi Adı: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3660-3667
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Context: Octreotide, a somatostatin analog, is commonly used in diazoxide unresponsive congenital hyperinsulinism (CHI) patients as a second-line therapy.